scholarly journals Clinical Characteristics of Children With COVID-19: A Multicenter Study in the United Arab Emirates

Author(s):  
Farah Ennab ◽  
Mariam ElSaban ◽  
Eman Khalaf ◽  
Hanieh Tabatabaei ◽  
Amar HK ◽  
...  
2021 ◽  
Author(s):  
Farah Ennab ◽  
Mariam ElSaban ◽  
Eman Khalaf ◽  
Hanieh Tabatabaei ◽  
Amar Hassan Khamis ◽  
...  

BACKGROUND Coronavirus disease 2019 (COVID-19) has infected over 123 million people globally. The first confirmed case in the United Arab Emirates (UAE) was reported on 29th January 2020.  COVID-19 has fared mildly in the pediatric population according to available literature out of early epicenters of the pandemic. To date there is a lack of published data about COVID-19 infection among children in the Arabian region. OBJECTIVE Investigate the clinical characteristics, laboratory findings, treatment, and outcomes of children with COVID-19. METHODS This cross-sectional multicenter study included children with confirmed COVID-19 infection admitted between March 1st and June 15th, 2020 to three large hospitals in Dubai, UAE. Serial COVID-19 polymerase chain reaction (PCR) testing was collected, and patients' demographics, pre-morbid clinical characteristics and inpatient hospital course were investigated. RESULTS 111 children were included in our study and represented 22 nationalities. Fifty-nine (53.2%) were boys. The mean age was 7 years (±5.3). 15.3% of children were younger than 1 year. Only 4 (3.6%) of the patients had pre-existing asthma all of whom had uneventful courses. At presentation 43 (38.7%) were asymptomatic, 68 (61.2%) had mild or moderate symptoms and none had severe illness requiring intensive care. Fever (20.7%), cough (19.8%) and rhinorrhea (15.3%) were the most common presenting symptoms and most symptoms resolved by day 5 of hospitalization. Most patients had no abnormality on chest x-ray. The most common laboratory abnormalities on admission included variations in neutrophil count (24.7%), aspartate transaminase (22.5%), alkaline phosphatase (36.7%) and lactate dehydrogenase (42.5%). Children were infrequently prescribed targeted medications, with only 4 (3.6%) receiving antibiotics. None of the 52 patients tested for viral co-infections were positive. COVID-19 PCR turned negative at a median of 10 days [6-14] after first positive test. Overall, there was no significant difference of time to negative PCR results between symptomatic and asymptomatic children. CONCLUSIONS This study of COVID19 presentations and characteristics presents a first look into the burden of COVID19 infection in the pediatric population in the UAE. We conclude that a large percentage of children experienced no symptoms, and severe disease is uncommon in the UAE. Various laboratory abnormalities were observed despite clinical stability. Ongoing surveillance, contact tracing and public health measures will be important to contain future outbreaks.


10.2196/29049 ◽  
2021 ◽  
Author(s):  
Farah Ennab ◽  
Mariam ElSaban ◽  
Eman Khalaf ◽  
Hanieh Tabatabaei ◽  
Amar Hassan Khamis ◽  
...  

2021 ◽  
Vol 10 (Supplement_2) ◽  
pp. S17-S18
Author(s):  
Farah Ennab ◽  
Mariam ElSaban ◽  
Eman Khalaf ◽  
Hanieh Tabatabaei ◽  
H K Amar ◽  
...  

Abstract Background To date, coronavirus disease-2019 (COVID-19) has infected over 82 million people globally. The first confirmed case in the United Arab Emirates (UAE)was reported on 29th January 2020. Current data suggests that children with COVID-19 have a mild disease course. There is a lack of extensive published data about COVID-19 infection among children in the Arabian Gulf region. Methods This cross-sectional multicenter study included children with confirmed COVID-19 infection admitted between March 1st and June 15th, 2020 to three large hospitals in Dubai, UAE. Serial nasal swabs for COVID-19 polymerase chain reaction (PCR) testing were collected during hospitalization. We investigated patients’ demographics,clinical characteristics, radiological and laboratory investigations during their inpatient hospital course. Results 111 children were included in our study and represented 22 nationalities. Fifty-nine (53.2%) were boys. The mean age was 7 years (±5.3), and 15.3% of children were younger than 1 year. Only 4 (3.6%) children had pre-existing asthma, all of whom had an uneventful clinical course. At presentation 43 (38.7%) were asymptomatic, 68 (61.2%) had mild or moderate symptoms and none had severe illness requiring intensive care. Fever (20.7%), cough (19.8%) and rhinorrhea (15.3%) were the most common presenting symptoms, most of which resolved by day 5 of hospitalization. Most of our patients had a normal chest x-ray. The most common laboratory abnormalities on admission included variations in neutrophil count (24.7%), aspartate transaminase (22.5%), alkaline phosphatase (36.7%) and lactate dehydrogenase (42.5%). Children were infrequently prescribed targeted medications, with only 4 (3.6%) receiving antibiotics. None of the 52 patients tested for viral co-infections were positive. COVID-19 PCR turned negative at a median of 10 days [6–14 days] after the first positive test. Overall, there was no significant difference in time to negative PCR between symptomatic and asymptomatic children. Conclusion This pediatric study of COVID-19 presents a first look into the burden of COVID-19 infection among children in the UAE. Patients had various laboratory abnormalities despite clinical stability. We conclude that a large percentage of children with COVID-19 infection experience no symptoms, and severe disease is uncommon in the UAE. Ongoing surveillance, contact tracing and public health measures will be essential in containing future outbreaks.


Author(s):  
Sandra Abou Kassm ◽  
Frédéric Limosin ◽  
Wadih Naja ◽  
Pierre Vandel ◽  
Marina Sánchez‐Rico ◽  
...  

Author(s):  
Marlon Yovera-Aldana ◽  
Sofia Sáenz-Bustamante ◽  
Yudith Quispe-Landeo ◽  
Rosa Agüero-Zamora ◽  
Julia Salcedo ◽  
...  

2011 ◽  
Vol 17 ◽  
pp. S31
Author(s):  
Byong Duk Ye ◽  
Suk-Kyun Yang ◽  
Won-Ho Kim ◽  
Jae Hee Cheon ◽  
Hyun-Soo Kim ◽  
...  

2020 ◽  
Vol 48 (8) ◽  
pp. 030006052094085
Author(s):  
Abdul Aziz Elsalmawy ◽  
Nadia S. Al-Ali ◽  
Yasser Yaghi ◽  
Hussein Assaggaf ◽  
Ghassan Maalouf ◽  
...  

Objective We aimed to describe the baseline clinical characteristics and fracture history of patients taking teriparatide in routine clinical practice in the Middle East (ME) subregional cohort of the Asia and Latin America Fracture Observational Study (ALAFOS). Methods Herein, we report baseline clinical characteristics of patients who were prescribed teriparatide (20 µg/day, subcutaneous injection) in four participant ME countries (Saudi Arabia, United Arab Emirates, Kuwait, and Lebanon). Results The ME cohort included 707 patients mean (SD) age 69.3 (11.6) years. Mean (SD) bone mineral density (BMD) T-scores at baseline were −3.13 (1.28) for lumbar spine, −2.88 (0.94) for total hip, and −2.65 (1.02) for femoral neck. Osteoporotic fractures after age 40 years were reported in 45.8% (vertebral fracture 14.4%, hip fracture 18.4%) and comorbidities in 57.4% of patients. Before starting teriparatide, 19.9% of patients took other osteoporosis medications. The median (Q1; Q3) EuroQoL 5-Dimension 5-Level visual analog scale score for perceived overall health status was 70 (50; 80). Mean (SD) worst back pain in the previous 24 hours was 4.0 (3.2) using a 10-point numeric rating scale. Conclusion This analysis indicated that in ME countries, teriparatide is usually prescribed to patients with low BMD and high comorbidities, with prior fractures.


1990 ◽  
Vol 76 (5) ◽  
pp. 429-433 ◽  
Author(s):  
◽  
Andrea Veronesi ◽  
Vittorina Zagonel ◽  
Diego Serraino ◽  
Andrea Ardizzoni ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document